Lista de obras -

A Requirement of STAT3 DNA Binding Precludes Th-1 Immunostimulatory Gene Expression by NF-κB in Tumors ⬇️

artículo científico publicado el 18 de abril de 2011

Assessing Therapeutic Efficacy of MEK Inhibition in a KRASG12C-Driven Mouse Model of Lung Cancer

artículo científico publicado en 2018

Autophagy sustains pancreatic cancer growth through both cell autonomous and non-autonomous mechanisms

artículo científico publicado en 2018

CD8+ T-cell immunosurveillance constrains lymphoid premetastatic myeloid cell accumulation

artículo científico publicado en 2014

CDK4/6 Inhibition Augments Anti-Tumor Immunity by Enhancing T Cell Activation.

artículo científico publicado en 2017

CDK7 Inhibition Potentiates Genome Instability Triggering Anti-tumor Immunity in Small Cell Lung Cancer

artículo científico publicado en 2019

Clinical and Translational Assessment of VEGFR1 as a Mediator of the Premetastatic Niche in High-Risk Localized Prostate Cancer.

artículo científico publicado en 2015

Epigenetic CRISPR screens identify Npm1 as a therapeutic vulnerability in non-small cell lung cancer

scientific article published on 09 July 2020

Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids.

artículo científico publicado en 2017

G-protein-coupled receptor agonist BV8/prokineticin-2 and STAT3 protein form a feed-forward loop in both normal and malignant myeloid cells.

artículo científico publicado en 2013

Ontogeny and Vulnerabilities of Drug-Tolerant Persisters in HER2+ Breast Cancer

artículo científico publicado en 2021

Prognostic Significance of B-Cells and pSTAT3 in Patients with Ovarian Cancer ⬇️

artículo científico publicado el 10 de enero de 2013

Pulsatile MEK Inhibition Improves Anti-tumor Immunity and T Cell Function in Murine Kras Mutant Lung Cancer ⬇️

artículo científico publicado en 2019

S1PR1 is an effective target to block STAT3 signaling in activated B cell-like diffuse large B-cell lymphoma.

artículo científico publicado en 2012

S1PR1 is crucial for accumulation of regulatory T cells in tumors via STAT3.

artículo científico publicado en 2014

S1PR1-STAT3 signaling is crucial for myeloid cell colonization at future metastatic sites.

artículo científico publicado en 2012

STAT3 in CD8+ T Cells Inhibits Their Tumor Accumulation by Downregulating CXCR3/CXCL10 Axis.

artículo científico publicado en 2015

STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors.

artículo científico publicado en 2010

Synergy of radiotherapy and PD-1 blockade in Kras-mutant lung cancer.

scientific article published on 16 June 2016

Targeting <i>HER2</i> Exon 20 Insertion-Mutant Lung Adenocarcinoma with a Novel Tyrosine Kinase Inhibitor Mobocertinib

artículo científico publicado en 2021

Targeting STAT3 in adoptively transferred T cells promotes their in vivo expansion and antitumor effects.

artículo científico publicado en 2010

Targeting Stat3 in the Myeloid Compartment Drastically Improves the In vivo Antitumor Functions of Adoptively Transferred T Cells ⬇️

artículo científico publicado el 14 de septiembre de 2010

ULK1 inhibition overcomes compromised antigen presentation and restores antitumor immunity in LKB1 mutant lung cancer

artículo científico publicado en 2021

Lista de obras de

A Requirement of STAT3 DNA Binding Precludes Th-1 Immunostimulatory Gene Expression by NF-κB in Tumors ⬇️

Assessing Therapeutic Efficacy of MEK Inhibition in a KRASG12C-Driven Mouse Model of Lung Cancer

Autophagy sustains pancreatic cancer growth through both cell autonomous and non-autonomous mechanisms

CD8+ T-cell immunosurveillance constrains lymphoid premetastatic myeloid cell accumulation

CDK4/6 Inhibition Augments Anti-Tumor Immunity by Enhancing T Cell Activation.

CDK7 Inhibition Potentiates Genome Instability Triggering Anti-tumor Immunity in Small Cell Lung Cancer

Clinical and Translational Assessment of VEGFR1 as a Mediator of the Premetastatic Niche in High-Risk Localized Prostate Cancer.

Epigenetic CRISPR screens identify Npm1 as a therapeutic vulnerability in non-small cell lung cancer

Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids.

G-protein-coupled receptor agonist BV8/prokineticin-2 and STAT3 protein form a feed-forward loop in both normal and malignant myeloid cells.

Ontogeny and Vulnerabilities of Drug-Tolerant Persisters in HER2+ Breast Cancer

Prognostic Significance of B-Cells and pSTAT3 in Patients with Ovarian Cancer ⬇️

Pulsatile MEK Inhibition Improves Anti-tumor Immunity and T Cell Function in Murine Kras Mutant Lung Cancer ⬇️

S1PR1 is an effective target to block STAT3 signaling in activated B cell-like diffuse large B-cell lymphoma.

S1PR1 is crucial for accumulation of regulatory T cells in tumors via STAT3.

S1PR1-STAT3 signaling is crucial for myeloid cell colonization at future metastatic sites.

STAT3 in CD8+ T Cells Inhibits Their Tumor Accumulation by Downregulating CXCR3/CXCL10 Axis.

STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors.

Synergy of radiotherapy and PD-1 blockade in Kras-mutant lung cancer.

Targeting <i>HER2</i> Exon 20 Insertion-Mutant Lung Adenocarcinoma with a Novel Tyrosine Kinase Inhibitor Mobocertinib

Targeting STAT3 in adoptively transferred T cells promotes their in vivo expansion and antitumor effects.

Targeting Stat3 in the Myeloid Compartment Drastically Improves the In vivo Antitumor Functions of Adoptively Transferred T Cells ⬇️

ULK1 inhibition overcomes compromised antigen presentation and restores antitumor immunity in LKB1 mutant lung cancer